Skip to main content
Journals

Global Insights Into Confidence and Self-Perception in Aesthetic Medicine: A 15-Country Survey Analysis

Aesthetic Surgery Journal Open Forum
Aesthetic Surgery Journal Open Forum

Authors: Shannon Humphrey, MD , Claudia Andrea Hernández, MD , Jose Raul Montes, MD , Je-Young Park, MD , Daria Voropai, MBBS, BDS , Katherine Warnell, PhD

Abstract: Nonsurgical aesthetic treatments have been found to improve patient confidence; however, the interplay between patient attitudes and aesthetic treatment experiences is not fully understood. The aim of this study was to further characterize the role of confidence and self-perception in the decision to pursue aesthetic treatments and in patient experience of outcomes. A total of 15,155 adults from 15 countries were recruited to participate in a device-agnostic online survey. Qualified participants were adults 21 to 75 years of age who had an aesthetic treatment in the past 12 months or would consider one in the next 24 months. Respondents reported a mismatch between their inner self and outward appearance, which may influence self-perception and social interactions. Individuals viewed aesthetic treatments as more than appearance enhancements, and many considered aesthetic treatments to be acts of self-care and empowerment, integrating them into their regular beauty routines. The strongest influence on individuals’ self-image was close personal relationships, whereas societal norms and social media played a secondary role. Results suggest that confidence derived through aesthetic treatments can shape self-perception and social well-being; moreover, the decision to obtain aesthetic treatment is not at odds with self-confidence and can be an empowering experience.

JOURNAL ARTICLE

Related Articles

Hyaluronic acid (HA) is widely used for lip augmentation; however, the safety and performance of injection techniques and instruments (needle vs cannula) remain unclear. The aim of this study was to evaluate the safety of HA injection techniques for lip augmentation and to assess patient satisfaction, injected volume, and associations with technique, instrument, and HA product.
AbobotulinumtoxinA (aboBoNT-A; Dysport®) is approved in China for treating glabellar lines (GLs) with fast onset of action (median: 2 days) and effectiveness up to 6 months (Chinese pivotal trial data), but real-world data remain limited. This study’s primary objective is to assess patient satisfaction following 3 cycles of aboBoNT-A treatment for moderate-to-severe GLs in a real-world setting.
Resident-run clinics (RRCs) have become an important component of plastic surgery training. This study evaluates outcomes from a longitudinal RRC focused on neuromodulator and soft tissue filler injections over a 5-year period. The aim of this study was to assess clinical outcomes, patient retention, resident experience by postgraduate year (PGY) level, and the safety of RRCs as a training model.
Poly-L-lactic acid (PLLA) is a biostimulatory injectable that restores midfacial volume through collagen neogenesis rather than gel-based filling. Controlled clinical evidence directly quantifying PLLA's volumetric efficacy remains limited. This study aimed to evaluate the efficacy, safety, and patient-reported outcomes of a Norberg Medical PLLA formulation for midface rejuvenation in a prospective, evaluator-blinded, split-face controlled study.
Collagenase clostridium histolyticum-aaes (CCH-aaes) is FDA-approved for cellulite treatment but was withdrawn because of high bruising incidence. Histological effects of CCH-aaes in humans remain poorly characterized. The aim of the study was to evaluate histopathologic changes in human subcutaneous tissue following CCH-aaes injection and compare injection techniques to identify strategies that reduce bruising.